ICON Public company profile
Company profile
ICON Public has 40,250 employees and is headquartered in Dublin, Ireland.
With 40,250 employees, ICON Public Limited Company provides outsourced development and commercialization services to pharmaceutical, biotechnology and medical device companies, as well as to government and public health organizations. Its work covers the clinical development process from compound selection through Phase I-IV studies, including trial management, data solutions, contract staffing and decentralized or hybrid trials. Its testing offering includes bioanalytical, biomarker, vaccine and central laboratory services, and its therapeutic areas include oncology, cardiovascular, central nervous system and infectious diseases. The group operates in Ireland, Europe, the United States and other international markets.
In the fiscal year ended December 2025, revenue reached 8.3 billion USD, up 0.8% from the previous year, and net income was 229.3 million USD. Ireland accounted for 38.6% of revenue, the United States for 30.6%, the rest of Europe for 19.3% and the rest of the world for 11.5%. The company is headquartered in Dublin, Ireland.
Company facts
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Headquarters
- South County Business Park, D18 X5R3, Dublin
- Employees
- 40,250
- Chief executive
- Barry Balfe
- Founded
- 1990
- Fiscal year
- January - December
- Listing
- ICLR · NASDAQ
- Currency
- USD
- ISIN
- IE0005711209
- Website
- iconplc.com
ICON Public and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| ICON PublicICLR | United States | $14.58B | 40,250 | 2.7% | 77.9 |
| Charles River Laboratories InternationalCRL | United States | $16.19B | 18,300 | 14.3% | 367.4 |
| RevvityRVTY | United States | $17.84B | 11,000 | 16.3% | 70.5 |
| Medpace HoldingsMEDP | United States | $18.27B | 6,600 | 21.4% | 36.3 |
| Guardant HealthGH | United States | $20.52B | 2,490 | -39.4% | — |
| Quest DiagnosticsDGX | United States | $28.85B | 60,000 | 14.9% | 26.1 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
